Gené E - Search Results

1

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.

Calvet X, Ruíz MÀ, Dosal A, Moreno L, López M, Figuerola A, Suarez D, Miquel M, Villoria A, Gené E. Calvet X, et al. Among authors: gene e. PLoS One. 2012;7(9):e45604. doi: 10.1371/journal.pone.0045604. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23029129 Free PMC article.

2

Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers--a cost-effectiveness analysis.

Gené E, Calvet X, Azagra R. Gené E, et al. Aliment Pharmacol Ther. 2000 Apr;14(4):433-42. doi: 10.1046/j.1365-2036.2000.00735.x. Aliment Pharmacol Ther. 2000. PMID: 10759623

3

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.

Calvet X, García N, López T, Gisbert JP, Gené E, Roque M. Calvet X, et al. Among authors: gene e. Aliment Pharmacol Ther. 2000 May;14(5):603-9. doi: 10.1046/j.1365-2036.2000.00744.x. Aliment Pharmacol Ther. 2000. PMID: 10792124

4

Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test.

Calvet X, Bustamante E, Montserrat A, Roqué M, Campo R, Gené E, Brullet E. Calvet X, et al. Among authors: gene e. Eur J Gastroenterol Hepatol. 2000 Aug;12(8):949-53. doi: 10.1097/00042737-200012080-00016. Eur J Gastroenterol Hepatol. 2000. PMID: 10958224

5

Limited usefulness of a seven-day twice-a-day quadruple therapy.

Garcia N, Calvet X, Gené E, Campo R, Brullet E. Garcia N, et al. Among authors: gene e. Eur J Gastroenterol Hepatol. 2000 Dec;12(12):1315-8. doi: 10.1097/00042737-200012120-00008. Eur J Gastroenterol Hepatol. 2000. PMID: 11192320 Clinical Trial.

6

Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.

Calvet X, Garcia N, Gené E, Campo R, Brullet E, Sanfeliu I. Calvet X, et al. Among authors: gene e. Aliment Pharmacol Ther. 2001 Jul;15(7):1061-5. doi: 10.1046/j.1365-2036.2001.00984.x. Aliment Pharmacol Ther. 2001. PMID: 11421883 Clinical Trial.

7

What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis.

Calvet X, Gené E, López T, Gisbert JP. Calvet X, et al. Among authors: gene e. Aliment Pharmacol Ther. 2001 Jul;15(7):1067-76. doi: 10.1046/j.1365-2036.2001.01031.x. Aliment Pharmacol Ther. 2001. PMID: 11421884

8

[Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].

Gené E, Calvet X, Azagra R, López T, Cubells MJ. Gené E, et al. Aten Primaria. 2002 May 15;29(8):486-94. doi: 10.1016/s0212-6567(02)70618-5. Aten Primaria. 2002. PMID: 12031222 Free PMC article. Spanish.

9

Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy.

Calvet X, Gené E. Calvet X, et al. Among authors: gene e. Helicobacter. 2002 Jun;7(3):216; author reply 216-7. doi: 10.1046/j.1523-5378.2002.00084_1.x. Helicobacter. 2002. PMID: 12047329 No abstract available.

10

[Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].

Calvet X, Gené E. Calvet X, et al. Among authors: gene e. Gastroenterol Hepatol. 2003 May;26(5):325-9. doi: 10.1016/s0210-5705(03)70366-5. Gastroenterol Hepatol. 2003. PMID: 12732108 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters